Paul Dewar of Davies Collison Cave Law Pty Ltd and Desmond Tan of Davies Collison Cave LLP provide overviews of the most important developments in IP in Australia and Singapore, including a series of important court decisions
Standard essential patents have long been a hot topic in China. Hou Guang and Jia Hongbo of Liu Shen & Associates explain the history and analyse recent developments
Germany and the UK both offer brand owners the means to protect unregistered IP rights. Angela Fox and Michael Nielen of Maucher Jenkins outline the similarities and differences between the rules in the two countries
The emergence of big domestic drug companies is reshaping Russia’s pharmaceutical patent landscape. Mikhail Khmara and Yana Lipatova of ARS-Patent explain how originator and generic companies can navigate the country’s changing IP rules
Technological changes to the way that plants are developed and grown pose challenges to the way that plant breeders’ rights are protected. Ylva Skoglösa and Isabel Cantallops Fiol of Valea outline the problems and offer potential solutions
Multinational companies and SMEs will need to think carefully about whether using the Unitary Patent and the UPC will save them money. Micaela Modiano and Alessandro Sanchini of Modiano outline the factors they need to take into account
Trade mark proprietors continue to push the boundaries of protection for non-traditional trade marks. Simon Barker of Freeths explains how their marks can be protected in Europe and the UK
